Avadel Pharmaceuticals (AVDL) Q2 2024 Earnings

8MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.66
-0.52
-0.38
-0.23

Details

Expected EPS
-0.2325
Actual EPS
-0.3
Surprise EPS
-0.07
Surprise Percent
+29.03%

Description

Avadel Pharmaceuticals (AVDL) has reported earnings of -0.3 per share for Q2 2024.

0 Comments

Share your thoughts